Showing results (361-370 of 495) with videos related to
Sort By:
Pageof 50
Lancet (London, England)|April 10, 2017
Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trialsMichael Böhm, Helmut Schumacher, Koon K Teo, et al.Hypertension (Dallas, Tex. : 1979)|April 25, 2024
Artificial Intelligence-Derived Risk Prediction: A Novel Risk Calculator Using Office and Ambulatory Blood PressurePedro Guimarães, Andreas Keller, Michael Böhm, et al.Journal of the American College of Cardiology|September 3, 2021
Effect of Heart Rate on the Outcome of Renal Denervation in Patients With Uncontrolled HypertensionMichael Böhm, Konstantinos Tsioufis, David E Kandzari, et al.Science Translational Medicine|May 1, 2015
Arterial microanatomy determines the success of energy-based renal denervation in controlling hypertensionAbraham R Tzafriri, John H Keating, Peter M Markham, et al.Deutsche Medizinische Wochenschrift (1946)|March 4, 2015
[Renal denervation in refractory hypertension: joint statement of the German hypertension league DHL eV and the German societies of cardiology, angiology, nephrology and radiology]Oliver Vonend, Michael Böhm, Siegfried Eckert, et al.Clinical Research in Cardiology : Official Journal of the German Cardiac Society|October 23, 2024
Long-term safety and efficacy of endovascular ultrasound renal denervation in resistant hypertension: 8-year results from the ACHIEVE studyVictor J M Zeijen, Sebastian Völz, Thomas Zeller, et al.Journal of Hypertension|September 9, 2016
The effect of renal denervation in moderate treatment-resistant hypertension with confirmed medication adherenceChristian Ott, Felix Mahfoud, Axel Schmid, et al.Open Heart|January 12, 2025
Evaluation of three diagnostic algorithms to reduce normal scan rates, radiation exposure and costs in patients with suspected chronic coronary syndrome referred for 82Rb-Positron Emission Tomography (82Rb-PET)Simon M Frey, Gabrielle Huré, Jan-Philipp Leibfarth, et al.Cardiovascular Revascularization Medicine : Including Molecular Interventions|September 22, 2020
Alcohol-Mediated Renal Sympathetic Neurolysis for the Treatment of Hypertension: The Peregrine™ Infusion CatheterStefan Bertog, Alok Sharma, Felix Mahfoud, et al.Journal of the American College of Cardiology|June 30, 2022
Empagliflozin Improves Outcomes in Patients With Heart Failure and Preserved Ejection Fraction Irrespective of AgeMichael Böhm, Javed Butler, Gerasimos Filippatos, et al.Pageof 50